BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11350542)

  • 21. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.
    Blumberg RS; Chopra S; Ibrahim R; Crawford J; Farraye FA; Zeldis JB; Berman MD
    Gastroenterology; 1988 Nov; 95(5):1399-402. PubMed ID: 2844622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis.
    Britto MR; Thomas LA; Balaratnam N; Griffiths AP; Duane PD
    Scand J Gastroenterol; 2000 Aug; 35(8):889-93. PubMed ID: 10994630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Iron storage disease].
    Horváth G; Dávid K
    Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary iron overload in the African and hepatocellular carcinoma.
    Kew MC; Asare GA
    Liver Int; 2007 Aug; 27(6):735-41. PubMed ID: 17617115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease progression and liver cancer in the ferroportin disease.
    Corradini E; Ferrara F; Pollicino T; Vegetti A; Abbati GL; Losi L; Raimondo G; Pietrangelo A
    Gut; 2007 Jul; 56(7):1030-2. PubMed ID: 17566043
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatocellular carcinoma presenting as a pyogenic liver abscess in a patient with hemochromatosis.
    Yang YH; Chen CC; Chiang JH; Kung SP; Tsay SH; Wang SS; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):53-7. PubMed ID: 10645051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour promotion versus tumour suppression in chronic hepatic iron overload.
    Bloomer SA; Brown KE
    Cell Biochem Funct; 2015 Jun; 33(4):241-8. PubMed ID: 26059599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [From iron accumulation to organ damage].
    Zaccone V; Gasbarrini G
    Minerva Med; 2012 Apr; 103(2):123-40. PubMed ID: 22513517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma in the thalassaemia syndromes.
    Borgna-Pignatti C; Vergine G; Lombardo T; Cappellini MD; Cianciulli P; Maggio A; Renda D; Lai ME; Mandas A; Forni G; Piga A; Bisconte MG
    Br J Haematol; 2004 Jan; 124(1):114-7. PubMed ID: 14675416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. African iron overload and hepatocellular carcinoma (HA-7-0-080).
    Moyo VM; Makunike R; Gangaidzo IT; Gordeuk VR; McLaren CE; Khumalo H; Saungweme T; Rouault T; Kiire CF
    Eur J Haematol; 1998 Jan; 60(1):28-34. PubMed ID: 9451425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.
    Bradbear RA; Bain C; Siskind V; Schofield FD; Webb S; Axelsen EM; Halliday JW; Bassett ML; Powell LW
    J Natl Cancer Inst; 1985 Jul; 75(1):81-4. PubMed ID: 2989605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum iron and copper and their relations to hepatocellular carcinoma in porphyria cutanea tarda and hemochromatosis patients--case report.
    Dabrowska E; Jabłońska-Kaszewska I; Lukasiak J; Dorosz A; Falkiewicz B
    Biofactors; 2000; 11(1-2):131-4. PubMed ID: 10705984
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.
    Yamauchi R; Takata K; Shinagawa Y; Tanaka T; Fukuda H; Fukuda S; Kunimoto H; Umeda K; Morihara D; Yokoyama K; Takeyama Y; Irie M; Shakado S; Mizoguchi M; Hisano S; Yoshimitsu K; Sakisaka S
    Intern Med; 2019 Mar; 58(5):661-665. PubMed ID: 30449774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.
    Sikorska K; Bernat A; Wroblewska A
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):461-479. PubMed ID: 27733315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis.
    Fellows IW; Stewart M; Jeffcoate WJ; Smith PG; Toghill PJ
    Gut; 1988 Nov; 29(11):1603-6. PubMed ID: 2850272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemochromatosis - modern condition of the problem.
    Voloshinа NB; Osipenko MF; Litvinova NV; Voloshin AN
    Ter Arkh; 2018 Apr; 90(3):107-112. PubMed ID: 30701865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: occurrence in noncirrhotic patients.
    Kew MD
    Hepatology; 1990 Jun; 11(6):1086-7. PubMed ID: 2163968
    [No Abstract]   [Full Text] [Related]  

  • 38. [Idiopathic hemochromatosis].
    Marin MG
    Minerva Med; 1985 Mar; 76(13):627-34. PubMed ID: 2986052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.
    Fargion S; Valenti L; Fracanzani AL
    Dig Liver Dis; 2011 Feb; 43(2):89-95. PubMed ID: 20739232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary hemochromatosis and cancer risk: more fuel to the fire?
    Mallory MA; Kowdley KV
    Gastroenterology; 2001 Nov; 121(5):1253-4. PubMed ID: 11677223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.